Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know

Della Corte Luigi; Foreste Virginia; Di Filippo ClaudiaGiampaolino PierluigiBifulco Giuseppe

首页> 外文期刊>Expert opinion on investigational drugs >Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know

【24h】

Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know

机译：Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Introduction

著录项

来源
《Expert opinion on investigational drugs》 |2021年第6期|543-554|共12页
作者
Della Corte Luigi; Foreste Virginia; Di Filippo ClaudiaGiampaolino PierluigiBifulco Giuseppe;
展开▼
作者单位

Univ Naples Federico II, Sch Med, Dept Neurosci Reprod Sci & Dent, Via Pansini 5, I-80131 Naples;

Univ Naples Federico II, Sch Med, Dept Publ Hlth, Naples, Italy;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类药学;
关键词
Epithelial ovarian cancer; PARP inhibitors; olaparib; niraparib; rucaparib; talazoparib; veliparib;

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号

Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know

摘要

著录项

相关主题

期刊订阅